Veiasu Dosage & Drug Information

Concise Prescribing Info

Contents

Gefitinib

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Adult patients w/ locally advanced or metastatic NSCLC w/ activating mutations of EGFR-TK

Dosage/Direction for Use

Adult 250 mg once daily.

Administration

May be taken with or without food: Tab may be dispersed in ½ glass of non-carbonated drinking water. No other liqd should be used. Drop the tab in water & w/o crushing it, stir until dispersed (approx 15 min). Drink the liqd immediately. Rinse the glass w/ another ½ glass of water & drink. Dispersed liqd may also be administered via a nasogastric tube.

Contraindications

Hypersensitivity. Lactation.

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01EB01 - gefitinib ; Belongs to the class of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Used in the treatment of cancer.

Regulatory Classification

POM

Presentation/Packing

Form

Veiasu FC tab 250 mg

Packing/Price

1's

Veiasu

gefitinib

Manufacturer:

Lotus International